Growth and growth factors in premature infants receiving dexamethasone for bronchopulmonary dysplasia

American Journal of Perinatology

Volumn 14, Issue 9, 1997, Pages 539-546

  Skinner, Alyson M ^a,b   Battin, Malcom ^a   Solimano, Alfonso ^a   Daaboul, Jorge ^a   Kitson, Hilary F ^a  

^a BC CHILDREN S HOSPITAL   (Canada)

^b CITY HOSPITAL   (United Kingdom)

Author keywords

Bronchopulmonary dysplasia; Dexamethasone; Growth

Indexed keywords

DEXAMETHASONE; GROWTH FACTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ARTICLE; BODY GROWTH; BODY HEIGHT; CLINICAL ARTICLE; DIETARY INTAKE; DRUG EFFECT; FEMALE; FETUS DEVELOPMENT; GESTATIONAL AGE; HUMAN; HYPERGLYCEMIA; INFANT; LUNG DYSPLASIA; MALE; METABOLIC CLEARANCE RATE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; WEIGHT GAIN;

EID: 0030712027     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994330     Document Type: Article

References (34)

1. Rush MG, Hazinski TA. Current therapy of bronchopulmonary dysplasia. Clin Perinatol 1992;19:563-90
2. Laron Z, Pertzolan A. The comparative effect of 6-fluoroprednisolone, 6 methylprednisolone and hydrocortisone on linear growth of children with congenital adrenal virilism and Addison's disease. J Pediatr 1968;73:774-82
3. Tanner JM. Normal growth and techniques of assessment. Clin Endocrinol Metab 1968;15:411-51
4. Harkavv KL, Scanlon JW, Chowdhry PK, Grylack LJ. Dexamethasone therapy for chronic lung disease in ventilator dependent infants: A controlled trial. J Pediatr 1989;115: 979-83
5. Noble-Jamieson CM, Roger R, Silvermann M. Dexamethasone in neonatal chronic disease: Pulmonary effects and intracranial complications. Eur J Pediatr 1989;148:365-7
6. Gluckman PD, Gunn AJ, Cutfield WS, et al. Congenital idiopathic growth hormone deficiency is associated with prenatal and early postnatal growth failure. J Pediatr 1992;121: 920-3
7. Harding JE, Liu L, Evans EC, Gluckman PD. IGF1 alters fetoplacental protein and carbohydrate metabolism in fetal sheep. Endocrinology 1994;134:1509-14
8. Clemens DR, Van Wyk JJ. Evidence for a functional role of endogenously produced somatomedin-like peptides in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells. J Clin Invest 1986;75:1 914-18
9. Northway WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline membrane disease. N Engl J Med 1967;276:357-68
10. Pennington JA. Bowes and Church's Food Values of Portions Commonly Used, 16th ed. Philadelphia: JB Lippincott Company, 1994: p 228
11. Avery ME, Tooley WH, Keller MB, et al. Is chronic lung disease in low birth weight infants preventable? A study of 8 centers. Pediatrics 1987;79:26-30
12. Vohr BR, Bell EF, Oh W. Infants with bronchopulmonary dysplasia. Growth pattern and neurologic and developmental outcome. Am J Dis Child 1982;136:443-7
13. Meisels SJ, Plunkett JW, Roloff DW, et al. Growth and development of preterm infants with respiratory distress syndrome and bronchopulmonary dysplasia. Pediatrics 1986;77: 345-52
14. Weinstein MR, Oh W. Oxygen consumption in infants with bronchopulmonary dysplasia. J Pediatr 1981;99:958-61
15. Yeh TF, McClenan DA, Ajayi OA, Pildes RS. Metabolic rate and energy balance in infants with bronchopulmonary dysplasia. J Pediatr 1988;114:448-51
16. Abram SH, Groothuis JR. Pathophysiology and treatment of bronchopulmonary dysplasia. Pediatr Clin of North Am 1994;41:227-315
17. Cummings JJ, D'Engenio DB, Gross SJ. Controlled trial of dexamethasone in preterm infants at risk for bronchopulmonary dysplasia. New Engl J Med 1989;320:1505-10
18. Martindale. Reynolds JEF (ed): The Extra Pharmacopoeia. London: The Pharmaceutical Press, 1993: p 716
19. Israel BA, Sherman FS, Guthrie RD. Cardiac hypertrophy associated with the use of dexamethasone in premature infants. Pediatr Res 1991;29:218A
20. Ferrara TB, Course SJ, Hoekstra RE. Side-effects and long-term follow-up of corticosteroid therapy in very low birth-weight infants with bronchopulmonary dysplasia. J Perinatol 1990;10:137-42
21. Wilson DM, Baldwin RB, Ariagno RL. A randomised, placebo-controlled trial of effects of dexamethasone on hypothalamic-pituitary-adrenal axis in preterm infants. J Pediatr 1988;113:764-8
22. Van Goudoever JB, Wattimena JDL, Carnielli VP, et al. Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia. J Pediatr 1994;113:112-18
23. Lubchenko L, Horner FA, Reed LH, et al. Sequelae of premature birth. Evaluation of premature infants of low birth weights at ten years of age. Am J Dis Child 1963;106;101-5
24. Gibson AT, Pearse RG, Wales JKH. Growth retardation after dexamethasone administration: assessment by knemometry. Arch Dis Child 1993;69:505-9
25. Miell JP, Corder R, Pralong EP, Gailard RC. Effects of dexamethasone on growth hormone releasing hormone, arginine and dopaminergic stimulated growth hormone stimulation and total plasma IGF1 in normal male volunteers. J Clin Endocrinol Metab 1991;72:675-81
26. Casaneuva FF, Burguera B, Muruais C, Dieguez C. Acute administration of corticoids: a new and peculiar stimulation of growth hormone secretion in man. J Clin Endocrinol Metab 1990;70:234-7
27. Miell JP, Taylor AM, Jones J, et al. The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers. J Endocrinol 1993;136:525-33
28. Luo JM, Murphy LJ. Regulation of insulin-like growth factor binding protein 3 expression by dexamethasone. Mol Cell Endocrinol 1990;74:213-19
29. Miell JP, Buchanan CR, Norman MR, et al. The evolution of changes in immunoreactive serum insulin-like growth factors (IGFs), IGF-binding proteins, circulating growth hormone (GH) and GH-binding protein as a result of short-term dexamethasone treatment. J Endocrinol 1994;142: 547-54
30. Bala RM, Lopatka J, Leung A, et al. Serurn immunoreactive somatomedin levels in normal adults, pregnant women at term, children at various ages and children with constitutionally delayed growth. J Clin Endocrinol Metab 1981;52: 508-12
31. Baxter RC, Martin JL. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest 1986;78:1504-12
32. Lassarre C, Hardouin S, Daffos F, et al. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationship with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res 1991;29:219-25
33. Isley WL, Underwood LE, Clemmons DR. Changes in plasma somatomedin-C in response to ingestion of diets with a variable protein and energy content. J Parenter Enteral Nutr 1984;8:364-9
34. Skinner AM, Cieslak Z, Solimano A. Early postnatal growth in bronchopulmonary dysplasia (abstract). Pediatr Res 1996;40:553